Current practice on covariate adjustment and stratified analysis —based on survey results by ASA oncology estimand working group conditional and marginal effect task force
This paper summarises the results from this survey and based on our findings, we provide some recommendations to establish consistency and clarifications on any widely misunderstood practices.
Authors
- Sarwar Islam Mozumder (ORCID: https://orcid.org/0000-0001-9644-7525)
- Jonathan Chipman
- Ray Lin
- Dong Xi (ORCID: https://orcid.org/0000-0003-1482-234X)
- Oleksandr Sverdlov (ORCID: https://orcid.org/0000-0002-1626-2588)
- Liming Li (ORCID: https://orcid.org/0009-0008-6870-0878)
- Jiajun Xu (ORCID: https://orcid.org/0000-0002-5058-2534)
- Jiawei Wei (ORCID: https://orcid.org/0000-0002-1605-6581)
Institutions
- Intermountain Healthcare (US)
- Johnson & Johnson (United States) (US)
- Novartis (China) (CN)
- Novartis (United States) (US)
- Johnson & Johnson (United Kingdom) (GB)
- Gilead Sciences (United States) (US)
- Health Data Research UK (GB)
Publication Details
- Journal
- BMC Medical Research Methodology
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1186/s12874-025-02670-7
- Primary Topic
- Advanced Causal Inference Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca